COMMUNIQUÉ DE PRESSE publié le 18/01/2024 à 13:00, il y a 2 années 7 mois Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:00, il y a 2 années 7 mois Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
COMMUNIQUÉ DE PRESSE publié le 15/11/2023 à 13:00, il y a 2 années 9 mois Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
COMMUNIQUÉ DE PRESSE publié le 15/06/2023 à 13:00, il y a 3 années 2 mois OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
COMMUNIQUÉ DE PRESSE publié le 09/05/2023 à 13:00, il y a 3 années 3 mois Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
COMMUNIQUÉ DE PRESSE publié le 04/05/2023 à 13:00, il y a 3 années 3 mois Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
COMMUNIQUÉ DE PRESSE publié le 03/05/2023 à 15:05, il y a 3 années 3 mois Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
COMMUNIQUÉ DE PRESSE publié le 01/05/2023 à 13:00, il y a 3 années 3 mois Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
COMMUNIQUÉ DE PRESSE publié le 30/03/2023 à 13:00, il y a 3 années 4 mois Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
COMMUNIQUÉ DE PRESSE publié le 29/03/2023 à 17:45, il y a 3 années 4 mois Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Publié le 21/08/2026 à 18:33, il y a 2 jours 16 heures 260821 BENETEAU Transaction sur actions propres
Publié le 18/08/2026 à 18:00, il y a 5 jours 16 heures KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Publié le 18/08/2026 à 17:45, il y a 5 jours 16 heures Mise à disposition du rapport financier annuel 2025-26
Publié le 24/08/2026 à 07:45, il y a 2 heures 54 minutes Sinopec Achieves Solid Operating Results in the First Half of 2026
Publié le 22/08/2026 à 05:50, il y a 2 jours 4 heures Battery X Metals Provides Board of Directors Update
Publié le 22/08/2026 à 04:55, il y a 2 jours 5 heures Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Publié le 22/08/2026 à 00:30, il y a 2 jours 10 heures BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Publié le 21/08/2026 à 23:00, il y a 2 jours 11 heures Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Publié le 24/08/2026 à 10:05, il y a 34 minutes Jungbunzlauer improves EcoVadis score and remains among the top 2% of companies worldwide
Publié le 24/08/2026 à 09:35, il y a 1 heure 4 minutes 2026 Taiwan Jewellery & Gem Fair to Take Place in November
Publié le 24/08/2026 à 09:00, il y a 1 heure 38 minutes Original-Research: SYNBIOTIC SE (von NuWays AG): Under review
Publié le 24/08/2026 à 09:00, il y a 1 heure 39 minutes Original-Research: Nabaltec AG (von NuWays AG): BUY